Compounds > yohimbine
Page last updated: 2024-08-20

yohimbine and Adenocarcinoma

yohimbine has been researched along with Adenocarcinoma in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19906 (85.71)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carpene, C; Cortinovis, C; Murat, JC; Paris, H; Viallard, V1
Bollinger, DW; Franklin, CC; Kim, HD; Turner, JT1
Daviaud, D; Mauriège, P; Paris, H; Sénard, JM1
Bylund, DB; Ray-Prenger, C; Turner, JT1
Galitzky, J; Paris, H; Taouis, M1
Bouscarel, B; Murat, JC; Paris, H1
Denis, C; Murat, JC; Paris, H1

Other Studies

7 other study(ies) available for yohimbine and Adenocarcinoma

ArticleYear
Characterization of alpha 2-adrenergic receptors in the human colon adenocarcinoma cell line HT 29 in culture by [3H]yohimbine binding.
    General pharmacology, 1983, Volume: 14, Issue:6

    Topics: Adenocarcinoma; Cell Line; Cell Membrane; Colonic Neoplasms; Humans; Kinetics; Neoplasm Proteins; Receptors, Adrenergic, alpha; Yohimbine

1983
Vasoactive intestinal peptide stimulates active K+ transport and Na(+)-K(+)-Cl- cotransport in HT-29 cells.
    The American journal of physiology, 1990, Volume: 258, Issue:2 Pt 1

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenocarcinoma; Amiloride; Biological Transport; Bumetanide; Carrier Proteins; Cell Line; Chlorides; Colonic Neoplasms; Humans; Isoquinolines; Kinetics; Norepinephrine; Ouabain; Piperazines; Potassium; Protein Kinase C; Sodium-Potassium-Chloride Symporters; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vasoactive Intestinal Peptide; Yohimbine

1990
Alpha 2-adrenoceptor in HT29 human colon adenocarcinoma cell-line: study of [3H](-)-adrenaline binding.
    European journal of pharmacology, 1989, Mar-21, Volume: 162, Issue:2

    Topics: Adenocarcinoma; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Cell Line; Cell Membrane; Clonidine; Colonic Neoplasms; Epinephrine; Guanylyl Imidodiphosphate; Humans; Receptors, Adrenergic, alpha; Yohimbine

1989
Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase.
    Molecular pharmacology, 1985, Volume: 28, Issue:5

    Topics: Adenocarcinoma; Adenylyl Cyclase Inhibitors; Adrenergic alpha-Agonists; Brimonidine Tartrate; Cell Line; Clonidine; Colforsin; Colonic Neoplasms; Dose-Response Relationship, Drug; Guanosine Triphosphate; Humans; Kinetics; Magnesium; Quinoxalines; Radioligand Assay; Receptors, Adrenergic, alpha; Vasoactive Intestinal Peptide; Yohimbine

1985
In vitro study of alpha 2-adrenoceptor turnover and metabolism using the adenocarcinoma cell line HT29.
    Molecular pharmacology, 1987, Volume: 32, Issue:5

    Topics: Adenocarcinoma; Adenylyl Cyclases; Adrenergic alpha-Antagonists; Animals; Cell Line; Cell Membrane; Colonic Neoplasms; Cyclic AMP; Cystamine; Kinetics; Phenoxybenzamine; Prazosin; Receptors, Adrenergic, alpha; Yohimbine

1987
Involvement of guanine nucleotide and sodium in regulation of yohimbine and clonidine binding sites in the HT29 human colon adenocarcinoma cell-line.
    General pharmacology, 1985, Volume: 16, Issue:6

    Topics: Adenocarcinoma; Binding, Competitive; Cell Line; Clonidine; Colonic Neoplasms; Epinephrine; Guanosine Triphosphate; Guanylyl Imidodiphosphate; Humans; Receptors, Adrenergic, alpha; Sodium; Yohimbine

1985
Hormonal control of fructose 2,6-bisphosphate concentration in the HT29 human colon adenocarcinoma cell line. Alpha 2-adrenergic agonists counteract effect of vasoactive intestinal peptide.
    The Biochemical journal, 1986, Nov-01, Volume: 239, Issue:3

    Topics: Adenocarcinoma; Brimonidine Tartrate; Cell Line; Clonidine; Colonic Neoplasms; Cyclic AMP; Epinephrine; Fructosediphosphates; Hexosediphosphates; Humans; Quinoxalines; Vasoactive Intestinal Peptide; Yohimbine

1986